AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lineage Cell Therapeutics Inc. Proxy Solicitation & Information Statement 2017

Jul 2, 2017

6895_rns_2017-07-02_96ace21c-76f6-40d1-a367-2d5fb2778926.htm

Proxy Solicitation & Information Statement

Opens in your device viewer

_________ false


��	2 380
.BIOTIME, INC
Corporation no: 876343	10834
- - -


	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	02/07/2017
	www.isa.gov.il			www.tase.co.il				Reference:	2017-02-055522	Time of broadcast: 08:40 08:35:55

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on SCHEDULE 14A INFORMATION �� - �� , �� - 31.7.2017
PRER14A_02072017_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: -1	Date of revision of form structure: 28/06/2017
Address: HARBOR BAY PARKWAY 1301 , ALAMEDA 94502 CALIFORNIA , U.S.A Tel: 5105213390 , Fax: 5105213389
E-mail address: [email protected] Company site: biotimeinc.com

Previous names of reporting entity:

Name of the Signatory: Gerzi Ilan Position of Signatory in the reporting corporation: Attorney/Legal Counsel Name of Employer Company: PEARL COHEN ZEDEK LATZER BARATZ
Address: Harbor Bay Parkway 1301 , Alameda 94502 Telephone: 510-5213390 Facsimile: 510-5213389 E-mail: [email protected] 1
U.S.A